Companies: 10,795·Total market cap: $144.5T
Dakshidin Corporation, Inc.

Dakshidin Corporation, Inc.

DKSCOTCHealthcare● Active
$0.00
+$0.00(+33.33%)
Market Cap$1771971
P/E Ratio
52W High$0.0007
52W Low$0.0001

Dakshidin Corporation, Inc. (DKSC) Shares Outstanding — Overview

Basic and diluted weighted average shares, YoY change, float context, and historical trend from SEC filings and FMP.

DKSC · shares outstanding · updated Jun 9, 2026

Key metrics

Basic Shares Outstanding · Weighted average · fiscal year
2.393B -28.36% YoY Change
FY · as of Dec 31, 2025 · Reported in USD
vs 3.340B in FY 2023
Diluted Shares Outstanding
2.393B
incl. options, RSUs, convertibles
Dilution Spread
+0.00%
Diluted vs Basic
YoY Change
-28.36%
year-over-year
Source: FMP /income-statement · /shares-float · SEC 10-K / 10-QUpdated: 2026-06-09

Shares Outstanding Growth Rate

3-Year CAGRdeclining
-2.3%
2021 → 2025
5-Year CAGRdeclining
-0.8%
2019 → 2025
10-Year CAGR

Negative CAGR typically indicates share buyback or retirement activity. Interpret alongside Splits and Financials tabs. Splits / Financials

Shares outstanding history

↓ Decrease — typically buyback / retirement
↑ Increase — issuance / equity compensation
Latest
* most recent reported · FMP /income-statement · weightedAverageShsOut

Annual shares outstanding by year

FY 2025Latest
Diluted Shares: 2.393B
2.393B
-28.36%
FY 2023
Diluted Shares: 3.340B
3.340B
+29.51%
FY 2022
Diluted Shares: 2.579B
2.579B
+0.65%
FY 2021
Diluted Shares: 2.562B
2.562B
+2.67%
FY 2020
Diluted Shares: 2.495B
2.495B
+0.00%
FMP /income-statement · weightedAverageShsOut · weightedAverageShsOutDilUnit: Billions (B)

Healthcare sector shares outstanding comparison

Shares Outstanding for similar companies or competitors in the Healthcare sector.

#SymbolCompanyShares (Basic)vs DKSC
#1
Merck & Co., Inc.MRK
Merck & Co., Inc.
2.502B+4.6%
#2
Johnson & JohnsonJNJ
Johnson & Johnson
2.429B+1.5%
#3
Dakshidin Corporation, Inc.DKSC
Dakshidin Corporation, Inc.YOU
2.393B
#4
AbbVie Inc.ABBV
AbbVie Inc.
1.780B-25.6%
#5
AstraZeneca PLCAZN
AstraZeneca PLC
1.550B-35.2%
#6
UnitedHealth Group IncorporatedUNH
UnitedHealth Group Incorporated
910.0M-62.0%
#7
Eli Lilly and CompanyLLY
Eli Lilly and Company
898.0M-62.5%

/company-screener · per-peer /income-statement · cache 86400s

Understanding Shares Outstanding

What Are Shares Outstanding? (Basic)

Dakshidin Corporation, Inc. (DKSC) shares outstanding is the total number of issued shares held by shareholders — the basis for Basic EPS and market capitalization. As of December 31, 2025, Dakshidin Corporation, Inc. reports 2.393B basic shares outstanding (weighted average).

Basic vs. Diluted Shares Outstanding

Dakshidin Corporation, Inc.'s basic shares outstanding (2.393B) represents currently issued shares. Diluted shares outstanding (2.393B) also includes potential shares from stock options, RSUs, and convertibles. Dilution spread: +0.00%.

Shares Outstanding vs. Float (Free Float)

Dakshidin Corporation, Inc.'s float is — (— of total shares outstanding) — shares freely available for public trading, excluding insider-held and restricted shares.

Float data from /shares-float reflects the most recent SEC filing period-end. The weighted average shares (from /income-statement) may differ — this is a normal reporting window difference, not a data error.

FMP /income-statement · /shares-float · SEC EDGAR · USD

About shares outstanding & methodology

Dakshidin Corporation, Inc. (DKSC) shares outstanding history from 2014 to 2025. Shares outstanding can be defined as the total number of shares held by all shareholders — including institutional investors, retail investors, and company insiders — assuming conversion of all convertible debt, securities, warrants, and options. This metric excludes the company's treasury shares.

Dakshidin Corporation, Inc. shares outstanding for the fiscal year ending December 31, 2025 were 2.393B, a 28.36% decline year-over-year. Dakshidin Corporation, Inc. FY 2025 shares outstanding were 2.393B, a -28.36% decline from FY 2023.

Dakshidin Corporation, Inc. is a leading company operating in the Healthcare sector. The company's share count trajectory — with a 10-year CAGR of — — is a key signal for investors evaluating capital return policy, EPS accretion, and long-term shareholder value creation.

Figures tie to SEC 10-K/10-Q income statement disclosures and FMP /income-statement · /shares-float where noted.

Frequently asked questions

DKSC shares outstanding · 4 questions

As of December 31, 2025, Dakshidin Corporation, Inc. (DKSC) has approximately 2.393B basic shares outstanding and 2.393B diluted shares outstanding. This represents a -28.36% year-over-year change from FY 2023 (3.340B). Dakshidin Corporation, Inc.'s declining share count is primarily driven by its share buyback program. For the complete historical data table, see the history table above.

DKSC shares outstandinghow many shares does DKSC haveDKSC basic shares 2025DKSC diluted shares

Data: FMP /income-statement · /shares-float · SEC EDGAR · weighted average basis · Dakshidin Corporation, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: 2026-06-09